(-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1319642 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of BCL6 mRNA CTD PMID:22079256 (E)-thiamethoxam decreases expression EXP 6480464 Thiamethoxam results in decreased expression of BCL6 mRNA CTD PMID:33533595 1,2-dichloroethane decreases expression EXP 6480464 ethylene dichloride results in decreased expression of BCL6 mRNA CTD PMID:28189721 , PMID:28960355 1,2-dimethylhydrazine increases expression EXP 6480464 1, 2-Dimethylhydrazine results in increased expression of BCL6 mRNA CTD PMID:22206623 17beta-estradiol multiple interactions ISO RGD:1319642 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of BCL6 mRNA CTD PMID:30165855 17beta-estradiol decreases expression ISO RGD:1319642 6480464 Estradiol results in decreased expression of BCL6 mRNA CTD PMID:31614463 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of BCL6 mRNA CTD PMID:17035482 , PMID:24058054 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1309345 6480464 Tetrachlorodibenzodioxin results in increased expression of BCL6 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1319642 6480464 Tetrachlorodibenzodioxin results in decreased expression of BCL6 mRNA CTD PMID:26238291 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of BCL6 mRNA CTD PMID:18684927 , PMID:25975270 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1319642 6480464 2-chlorodibenzo-4-dioxin inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of BCL6 protein] more ... CTD PMID:25543051 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of BCL6 mRNA CTD PMID:21570461 , PMID:28922406 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1309345 6480464 Tetrachlorodibenzodioxin affects the expression of BCL6 mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1319642 6480464 Tetrachlorodibenzodioxin results in increased expression of BCL6 mRNA, Tetrachlorodibenzodioxin results in increased expression of BCL6 protein CTD PMID:21802500 , PMID:27546522 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with Lipopolysaccharides] results in increased expression of BCL6 protein CTD PMID:20348231 2,4-dinitrotoluene affects expression ISO RGD:1309345 6480464 2, 4-dinitrotoluene affects the expression of BCL6 mRNA CTD PMID:21346803 2-hydroxypropanoic acid increases expression ISO RGD:1319642 6480464 Lactic Acid results in increased expression of BCL6 mRNA CTD PMID:30851411 3,3',5,5'-tetrabromobisphenol A increases expression EXP 6480464 tetrabromobisphenol A results in increased expression of BCL6 mRNA CTD PMID:25172293 3-methylcholanthrene increases expression EXP 6480464 Methylcholanthrene results in increased expression of BCL6 mRNA CTD PMID:20713471 , PMID:25926378 3-methylcholanthrene multiple interactions ISO RGD:1319642 6480464 Methylcholanthrene promotes the reaction [AHR protein binds to BCL6 promoter] CTD PMID:20348232 4,4'-sulfonyldiphenol decreases expression EXP 6480464 bis(4-hydroxyphenyl)sulfone results in decreased expression of BCL6 mRNA CTD PMID:33297965 4-hydroxynon-2-enal increases expression EXP 6480464 4-hydroxy-2-nonenal results in increased expression of BCL6 mRNA CTD PMID:19191707 4-phenylbutyric acid increases expression ISO RGD:1319642 6480464 4-phenylbutyric acid results in increased expression of BCL6 mRNA CTD PMID:14583596 5-aza-2'-deoxycytidine affects expression ISO RGD:1319642 6480464 Decitabine affects the expression of BCL6 mRNA CTD PMID:23300844 5-formyltetrahydrofolic acid multiple interactions ISO RGD:1319642 6480464 Leucovorin inhibits the reaction [Pyrimethamine inhibits the reaction [Oncostatin M results in increased expression of BCL6 mRNA]] CTD PMID:34953855 6-propyl-2-thiouracil decreases expression ISO RGD:1309345 6480464 Propylthiouracil results in decreased expression of BCL6 mRNA CTD PMID:24780913 6-propyl-2-thiouracil increases expression ISO RGD:1309345 6480464 Propylthiouracil results in increased expression of BCL6 mRNA CTD PMID:25825206 7,12-dimethyltetraphene increases expression EXP 6480464 9 more ... CTD PMID:32553695 acrylamide increases expression ISO RGD:1309345 6480464 Acrylamide results in increased expression of BCL6 mRNA CTD PMID:28959563 aflatoxin B1 decreases methylation ISO RGD:1319642 6480464 Aflatoxin B1 results in decreased methylation of BCL6 gene CTD PMID:27153756 all-trans-retinoic acid increases expression ISO RGD:1319642 6480464 Tretinoin results in increased expression of BCL6 mRNA CTD PMID:33167477 amphetamine increases expression ISO RGD:1309345 6480464 Amphetamine results in increased expression of BCL6 mRNA CTD PMID:30779732 antirheumatic drug decreases expression ISO RGD:1319642 6480464 Antirheumatic Agents results in decreased expression of BCL6 mRNA CTD PMID:25339124 aripiprazole multiple interactions ISO RGD:1319642 6480464 [Aripiprazole co-treated with Ozone] results in decreased expression of BCL6 mRNA CTD PMID:31476115 aristolochic acid A multiple interactions ISO RGD:1309345 6480464 [aristolochic acid I co-treated with aristolochic acid II] results in decreased expression of BCL6 mRNA CTD PMID:23912714 aristolochic acid A increases expression ISO RGD:1319642 6480464 aristolochic acid I results in increased expression of BCL6 mRNA CTD PMID:33212167 arsane affects methylation ISO RGD:1319642 6480464 Arsenic affects the methylation of BCL6 gene CTD PMID:25304211 arsane multiple interactions ISO RGD:1319642 6480464 UCA1 mRNA promotes the reaction [Arsenic results in increased expression of BCL6 mRNA] CTD PMID:29248574 arsane increases expression ISO RGD:1319642 6480464 Arsenic results in increased expression of BCL6 mRNA CTD PMID:29248574 arsenic atom affects methylation ISO RGD:1319642 6480464 Arsenic affects the methylation of BCL6 gene CTD PMID:25304211 arsenic atom multiple interactions ISO RGD:1319642 6480464 UCA1 mRNA promotes the reaction [Arsenic results in increased expression of BCL6 mRNA] CTD PMID:29248574 arsenic atom increases expression ISO RGD:1319642 6480464 Arsenic results in increased expression of BCL6 mRNA CTD PMID:29248574 arsenous acid increases expression ISO RGD:1319642 6480464 Arsenic Trioxide results in increased expression of BCL6 mRNA CTD PMID:24356939 benzene increases expression ISO RGD:1319642 6480464 Benzene results in increased expression of BCL6 mRNA CTD PMID:20359517 benzene decreases expression EXP 6480464 Benzene results in decreased expression of BCL6 mRNA CTD PMID:34624356 benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene metabolite results in increased expression of BCL6 mRNA, Benzo(a)pyrene results in increased expression of BCL6 mRNA CTD PMID:20713471 , PMID:32553695 benzo[a]pyrene affects methylation ISO RGD:1319642 6480464 Benzo(a)pyrene affects the methylation of BCL6 5' UTR CTD PMID:27901495 benzo[a]pyrene decreases expression ISO RGD:1319642 6480464 Benzo(a)pyrene metabolite results in decreased expression of BCL6 mRNA CTD PMID:24356939 benzo[a]pyrene increases expression ISO RGD:1319642 6480464 Benzo(a)pyrene results in increased expression of BCL6 mRNA CTD PMID:21802500 bisphenol A decreases expression ISO RGD:1319642 6480464 bisphenol A results in decreased expression of BCL6 mRNA CTD PMID:22576693 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of BCL6 mRNA CTD PMID:33221593 bisphenol A decreases expression ISO RGD:1309345 6480464 bisphenol A results in decreased expression of BCL6 mRNA CTD PMID:30816183 bisphenol A affects expression ISO RGD:1309345 6480464 bisphenol A affects the expression of BCL6 mRNA CTD PMID:30903817 bisphenol A affects methylation EXP 6480464 bisphenol A affects the methylation of BCL6 promoter CTD PMID:27334623 bisphenol A increases expression ISO RGD:1309345 6480464 bisphenol A results in increased expression of BCL6 mRNA CTD PMID:25181051 bisphenol A increases methylation ISO RGD:1319642 6480464 bisphenol A results in increased methylation of BCL6 gene CTD PMID:22576693 boron nitride increases expression ISO RGD:1319642 6480464 boron nitride results in increased expression of BCL6 mRNA CTD PMID:30644070 bortezomib increases expression ISO RGD:1319642 6480464 Bortezomib results in increased expression of BCL6 mRNA CTD PMID:20977926 cadmium atom multiple interactions ISO RGD:1319642 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of BCL6 mRNA, [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of BCL6 mRNA CTD PMID:29741670 , PMID:35301059 cadmium dichloride multiple interactions ISO RGD:1319642 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of BCL6 mRNA, [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of BCL6 mRNA CTD PMID:29741670 , PMID:35301059 caffeine affects phosphorylation ISO RGD:1319642 6480464 Caffeine affects the phosphorylation of BCL6 protein CTD PMID:35688186 carbon nanotube increases expression EXP 6480464 Nanotubes, Carbon results in increased expression of BCL6 mRNA CTD PMID:25620056 carbon nanotube decreases expression EXP 6480464 Nanotubes, Carbon analog results in decreased expression of BCL6 mRNA CTD PMID:25554681 , PMID:25620056 ciglitazone multiple interactions ISO RGD:1319642 6480464 [ciglitazone binds to PPARG protein alternative form] which results in increased expression of BCL6 mRNA CTD PMID:16197558 ciguatoxin CTX1B affects expression EXP 6480464 Ciguatoxins affects the expression of BCL6 mRNA CTD PMID:18353800 cisplatin increases expression ISO RGD:1319642 6480464 Cisplatin results in increased expression of BCL6 mRNA CTD PMID:21532991 cisplatin affects expression ISO RGD:1319642 6480464 Cisplatin affects the expression of BCL6 mRNA CTD PMID:23300844 cisplatin multiple interactions ISO RGD:1319642 6480464 [Cisplatin co-treated with Paclitaxel] results in increased expression of BCL6 mRNA CTD PMID:20705681 clobetasol increases expression EXP 6480464 Clobetasol results in increased expression of BCL6 mRNA CTD PMID:27462272 cobalt dichloride increases expression ISO RGD:1319642 6480464 cobaltous chloride results in increased expression of BCL6 mRNA CTD PMID:22941251 copper(II) sulfate increases expression ISO RGD:1319642 6480464 Copper Sulfate results in increased expression of BCL6 mRNA CTD PMID:19549813 crocidolite asbestos increases expression ISO RGD:1319642 6480464 Asbestos, Crocidolite results in increased expression of BCL6 mRNA CTD PMID:18687144 Cuprizon increases expression ISO RGD:1309345 6480464 Cuprizone results in increased expression of BCL6 mRNA CTD PMID:27523638 Cuprizon decreases expression ISO RGD:1309345 6480464 Cuprizone results in decreased expression of BCL6 mRNA CTD PMID:26577399 cyclophosphamide decreases expression EXP 6480464 Cyclophosphamide results in decreased expression of BCL6 mRNA CTD PMID:21041162 cyclophosphamide decreases expression ISO RGD:1319642 6480464 Cyclophosphamide metabolite results in decreased expression of BCL6 mRNA CTD PMID:24356939 cyclosporin A decreases expression ISO RGD:1319642 6480464 Cyclosporine results in decreased expression of BCL6 mRNA CTD PMID:20106945 , PMID:25562108 cypermethrin multiple interactions EXP 6480464 [[[cypermethrin results in decreased expression of MIR155 mRNA] which results in increased expression of BCL6 mRNA] which results in decreased expression of MAP2K4 protein] which results in decreased phosphorylation of and results in decreased activity of MAPK8 protein more ... CTD PMID:29471534 DDT increases expression ISO RGD:1319642 6480464 DDT results in increased expression of BCL6 mRNA CTD PMID:33728745 deoxynivalenol increases expression EXP 6480464 deoxynivalenol results in increased expression of BCL6 mRNA CTD PMID:22968694 deoxynivalenol increases expression ISO RGD:1319642 6480464 deoxynivalenol results in increased expression of BCL6 mRNA CTD PMID:31863870 dexamethasone decreases expression EXP 6480464 Dexamethasone results in decreased expression of BCL6 mRNA CTD PMID:21041162 diarsenic trioxide increases expression ISO RGD:1319642 6480464 Arsenic Trioxide results in increased expression of BCL6 mRNA CTD PMID:24356939 diazinon affects expression ISO RGD:1309345 6480464 Diazinon affects the expression of BCL6 mRNA CTD PMID:22546817 dibenz[a,h]anthracene decreases expression EXP 6480464 1 more ... CTD PMID:26377693 dichloromethane increases expression ISO RGD:1319642 6480464 Methylene Chloride results in increased expression of BCL6 mRNA CTD PMID:20359517 dichloromethane increases expression EXP 6480464 Methylene Chloride results in increased expression of BCL6 mRNA CTD PMID:28392392 diclofenac decreases expression EXP 6480464 Diclofenac results in decreased expression of BCL6 mRNA CTD PMID:26934552 dicrotophos increases expression ISO RGD:1319642 6480464 dicrotophos results in increased expression of BCL6 mRNA CTD PMID:28302478 dieldrin affects expression ISO RGD:1309345 6480464 Dieldrin affects the expression of BCL6 mRNA CTD PMID:22546817 diethylstilbestrol decreases expression EXP 6480464 Diethylstilbestrol results in decreased expression of BCL6 mRNA CTD PMID:21041162 dorsomorphin multiple interactions ISO RGD:1319642 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO RGD:1319642 6480464 Doxorubicin results in decreased expression of BCL6 mRNA CTD PMID:29803840 epoxiconazole affects expression EXP 6480464 epoxiconazole affects the expression of BCL6 mRNA CTD PMID:35436446 ethanol multiple interactions ISO RGD:1319642 6480464 [[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of BCL6 mRNA CTD PMID:29432896 ethanol affects expression EXP 6480464 Ethanol affects the expression of BCL6 mRNA CTD PMID:30319688 ethylbenzene increases expression ISO RGD:1319642 6480464 ethylbenzene results in increased expression of BCL6 mRNA CTD PMID:20359517 fluoranthene multiple interactions EXP 6480464 [1-methylanthracene co-treated with fluoranthene] results in increased expression of BCL6 mRNA CTD PMID:28329830 formaldehyde increases expression ISO RGD:1319642 6480464 Formaldehyde results in increased expression of BCL6 mRNA CTD PMID:20655997 , PMID:23416264 furan increases methylation ISO RGD:1309345 6480464 furan results in increased methylation of BCL6 gene CTD PMID:22079235 furan increases expression ISO RGD:1309345 6480464 furan results in increased expression of BCL6 mRNA CTD PMID:26194646 gamma-hexachlorocyclohexane increases expression ISO RGD:1319642 6480464 Hexachlorocyclohexane results in increased expression of BCL6 mRNA CTD PMID:24356939 gemcitabine increases expression ISO RGD:1319642 6480464 Gemcitabine results in increased expression of BCL6 mRNA CTD PMID:17039268 genistein decreases expression ISO RGD:1319642 6480464 Genistein results in decreased expression of BCL6 mRNA CTD PMID:26865667 gentamycin increases expression ISO RGD:1309345 6480464 Gentamicins results in increased expression of BCL6 mRNA CTD PMID:22061828 , PMID:33387578 geraniol increases expression ISO RGD:1319642 6480464 geraniol results in increased expression of BCL6 mRNA CTD PMID:27683099 GW 501516 multiple interactions ISO RGD:1319642 6480464 BCL6 mutant form inhibits the reaction [GW 501516 inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA]] more ... CTD PMID:23737761 hydrazine decreases expression EXP 6480464 hydrazine results in decreased expression of BCL6 mRNA CTD PMID:15282401 hydrogen peroxide affects expression ISO RGD:1319642 6480464 Hydrogen Peroxide affects the expression of BCL6 mRNA CTD PMID:20044591 Indeno[1,2,3-cd]pyrene decreases expression EXP 6480464 indeno(1 more ... CTD PMID:26377693 indole-3-methanol multiple interactions ISO RGD:1309345 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of BCL6 mRNA CTD PMID:22129741 leflunomide increases expression ISO RGD:1319642 6480464 leflunomide results in increased expression of BCL6 mRNA CTD PMID:28988120 lipopolysaccharide multiple interactions EXP 6480464 (+)-JQ1 compound inhibits the reaction [[Lipopolysaccharides co-treated with IL4 protein] results in increased expression of BCL6 protein] more ... CTD PMID:20348231 , PMID:25656449 lipopolysaccharide decreases expression EXP 6480464 Lipopolysaccharides results in decreased expression of BCL6 mRNA CTD PMID:19675145 lipopolysaccharide affects expression EXP 6480464 Lipopolysaccharides affects the expression of BCL6 protein CTD PMID:20348231 lipopolysaccharide decreases expression ISO RGD:1319642 6480464 Lipopolysaccharides results in decreased expression of BCL6 mRNA CTD PMID:25725100 menadione affects expression ISO RGD:1319642 6480464 Vitamin K 3 affects the expression of BCL6 mRNA CTD PMID:20044591 metformin increases expression ISO RGD:1309345 6480464 Metformin results in increased expression of BCL6 mRNA CTD PMID:31324951 methamphetamine multiple interactions ISO RGD:1309345 6480464 [Methamphetamine co-treated with SCH 23390] results in increased expression of BCL6 mRNA CTD PMID:19564919 methamphetamine increases expression ISO RGD:1309345 6480464 Methamphetamine results in increased expression of BCL6 mRNA CTD PMID:19564919 methapyrilene decreases expression ISO RGD:1309345 6480464 Methapyrilene results in decreased expression of BCL6 mRNA CTD PMID:30467583 methotrexate multiple interactions ISO RGD:1319642 6480464 Methotrexate inhibits the reaction [Oncostatin M results in increased expression of BCL6 mRNA] CTD PMID:34953855 methylmercury chloride increases expression ISO RGD:1319642 6480464 methylmercuric chloride results in increased expression of BCL6 mRNA CTD PMID:28001369 mono(2-ethylhexyl) phthalate increases expression ISO RGD:1309345 6480464 mono-(2-ethylhexyl)phthalate results in increased expression of BCL6 mRNA CTD PMID:16809437 N,N-diethyl-m-toluamide multiple interactions ISO RGD:1309345 6480464 [Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of BCL6 mRNA CTD PMID:28659758 N-acetyl-L-cysteine multiple interactions ISO RGD:1309345 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of BCL6 mRNA CTD PMID:22129741 N-nitrosodiethylamine multiple interactions ISO RGD:1309345 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of BCL6 mRNA CTD PMID:22129741 nefazodone increases expression ISO RGD:1309345 6480464 nefazodone results in increased expression of BCL6 mRNA CTD PMID:24136188 nickel dichloride affects expression ISO RGD:1309345 6480464 nickel chloride affects the expression of BCL6 mRNA CTD PMID:22546817 niclosamide multiple interactions EXP 6480464 Niclosamide affects the reaction [FAS protein mutant form affects the expression of BCL6 mRNA], Niclosamide affects the reaction [FAS protein mutant form affects the expression of BCL6 protein] CTD PMID:33632240 nitrofen decreases expression ISO RGD:1309345 6480464 nitrofen results in decreased expression of BCL6 mRNA CTD PMID:33484710 o-xylene increases expression ISO RGD:1319642 6480464 2-xylene results in increased expression of BCL6 mRNA CTD PMID:20359517 ochratoxin A decreases expression ISO RGD:1309345 6480464 ochratoxin A results in decreased expression of BCL6 mRNA CTD PMID:23358140 orphenadrine affects expression ISO RGD:1309345 6480464 Orphenadrine affects the expression of BCL6 mRNA CTD PMID:23665939 oxaliplatin multiple interactions ISO RGD:1309345 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of BCL6 mRNA CTD PMID:25729387 ozone multiple interactions ISO RGD:1319642 6480464 [Aripiprazole co-treated with Ozone] results in decreased expression of BCL6 mRNA CTD PMID:31476115 ozone decreases expression ISO RGD:1319642 6480464 Ozone results in decreased expression of BCL6 mRNA CTD PMID:31476115 p-chloromercuribenzoic acid increases expression ISO RGD:1319642 6480464 p-Chloromercuribenzoic Acid results in increased expression of BCL6 mRNA CTD PMID:26272509 p-chloromercuribenzoic acid multiple interactions ISO RGD:1319642 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BCL6 mRNA CTD PMID:27188386 paclitaxel multiple interactions ISO RGD:1319642 6480464 [Cisplatin co-treated with Paclitaxel] results in increased expression of BCL6 mRNA CTD PMID:20705681 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of BCL6 mRNA CTD PMID:15606129 paracetamol increases expression ISO RGD:1309345 6480464 Acetaminophen results in increased expression of BCL6 mRNA CTD PMID:33387578 permethrin multiple interactions ISO RGD:1309345 6480464 [Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of BCL6 mRNA CTD PMID:28659758 phenobarbital decreases expression EXP 6480464 Phenobarbital results in decreased expression of BCL6 mRNA CTD PMID:23091169 phenylmercury acetate increases expression ISO RGD:1319642 6480464 Phenylmercuric Acetate results in increased expression of BCL6 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1319642 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BCL6 mRNA CTD PMID:27188386 pirinixic acid multiple interactions EXP 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of BCL6 mRNA CTD PMID:19710929 pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of BCL6 mRNA CTD PMID:23811191 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of BCL6 mRNA CTD PMID:18445702 potassium chromate increases expression ISO RGD:1319642 6480464 potassium chromate(VI) results in increased expression of BCL6 mRNA CTD PMID:22079256 potassium chromate multiple interactions ISO RGD:1319642 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of BCL6 mRNA CTD PMID:22079256 progesterone increases expression ISO RGD:1319642 6480464 Progesterone results in increased expression of BCL6 mRNA CTD PMID:33728745 Pyridostigmine bromide multiple interactions ISO RGD:1309345 6480464 [Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of BCL6 mRNA CTD PMID:28659758 pyrimethamine multiple interactions ISO RGD:1319642 6480464 Leucovorin inhibits the reaction [Pyrimethamine inhibits the reaction [Oncostatin M results in increased expression of BCL6 mRNA]], Pyrimethamine inhibits the reaction [Oncostatin M results in increased expression of BCL6 mRNA] CTD PMID:34953855 rac-lactic acid increases expression ISO RGD:1319642 6480464 Lactic Acid results in increased expression of BCL6 mRNA CTD PMID:30851411 raloxifene increases expression ISO RGD:1319642 6480464 Raloxifene Hydrochloride results in increased expression of BCL6 mRNA CTD PMID:16497877 resveratrol increases expression ISO RGD:1319642 6480464 resveratrol results in increased expression of BCL6 mRNA CTD PMID:12002526 , PMID:12569576 resveratrol multiple interactions EXP 6480464 Resveratrol inhibits the reaction [titanium dioxide results in decreased expression of BCL6 mRNA] CTD PMID:31298478 resveratrol decreases expression ISO RGD:1319642 6480464 resveratrol results in decreased expression of BCL6 protein CTD PMID:17088997 rotenone increases expression ISO RGD:1309345 6480464 Rotenone results in increased expression of BCL6 mRNA CTD PMID:28374803 SB 431542 multiple interactions ISO RGD:1319642 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 SCH 23390 multiple interactions ISO RGD:1309345 6480464 [Methamphetamine co-treated with SCH 23390] results in increased expression of BCL6 mRNA CTD PMID:19564919 silicon dioxide decreases expression ISO RGD:1319642 6480464 Silicon Dioxide analog results in decreased expression of BCL6 mRNA CTD PMID:25895662 silicon dioxide decreases expression EXP 6480464 Silicon Dioxide results in decreased expression of BCL6 mRNA CTD PMID:19073995 silver atom increases expression ISO RGD:1319642 6480464 Silver results in increased expression of BCL6 mRNA CTD PMID:26014281 silver(0) increases expression ISO RGD:1319642 6480464 Silver results in increased expression of BCL6 mRNA CTD PMID:26014281 sodium arsenate increases expression EXP 6480464 sodium arsenate results in increased expression of BCL6 mRNA CTD PMID:21795629 sodium arsenite increases mutagenesis EXP 6480464 sodium arsenite results in increased mutagenesis of BCL6 gene CTD PMID:25787150 sodium arsenite increases expression ISO RGD:1319642 6480464 sodium arsenite results in increased expression of BCL6 mRNA CTD PMID:12760830 sodium dichromate increases expression EXP 6480464 sodium bichromate results in increased expression of BCL6 mRNA CTD PMID:22155349 sodium dichromate decreases expression ISO RGD:1309345 6480464 sodium bichromate results in decreased expression of BCL6 mRNA CTD PMID:25993096 sodium stibogluconate decreases expression ISO RGD:1319642 6480464 Antimony Sodium Gluconate results in decreased expression of BCL6 protein CTD PMID:27546522 styrene decreases expression EXP 6480464 Styrene results in decreased expression of BCL6 mRNA CTD PMID:28951217 sulforaphane increases expression ISO RGD:1319642 6480464 sulforaphane results in increased expression of BCL6 mRNA CTD PMID:26833863 sulforaphane decreases expression ISO RGD:1319642 6480464 sulforaphane results in decreased expression of BCL6 mRNA CTD PMID:31838189 sunitinib decreases expression ISO RGD:1319642 6480464 Sunitinib results in decreased expression of BCL6 mRNA CTD PMID:31533062 tamoxifen increases expression EXP 6480464 Tamoxifen results in increased expression of BCL6 mRNA CTD PMID:25123088 tamoxifen affects expression EXP 6480464 Tamoxifen affects the expression of BCL6 mRNA CTD PMID:20937368 tamoxifen increases expression ISO RGD:1319642 6480464 Tamoxifen results in increased expression of BCL6 mRNA CTD PMID:15604281 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of BCL6 mRNA CTD PMID:17484886 , PMID:31919559 tetrachloromethane multiple interactions EXP 6480464 PLG gene mutant form promotes the reaction [Carbon Tetrachloride results in increased expression of BCL6 mRNA] CTD PMID:16006527 thiamethoxam decreases expression EXP 6480464 Thiamethoxam results in decreased expression of BCL6 mRNA CTD PMID:33533595 thioacetamide decreases expression ISO RGD:1309345 6480464 Thioacetamide results in decreased expression of BCL6 mRNA CTD PMID:34492290 titanium dioxide decreases expression EXP 6480464 titanium dioxide results in decreased expression of BCL6 mRNA CTD PMID:29264374 , PMID:31298478 titanium dioxide multiple interactions EXP 6480464 Resveratrol inhibits the reaction [titanium dioxide results in decreased expression of BCL6 mRNA] CTD PMID:31298478 toluene increases expression ISO RGD:1319642 6480464 Toluene results in increased expression of BCL6 mRNA CTD PMID:20359517 topotecan multiple interactions ISO RGD:1309345 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of BCL6 mRNA CTD PMID:25729387 trichloroethene increases expression ISO RGD:1319642 6480464 Trichloroethylene results in increased expression of BCL6 mRNA CTD PMID:20359517 trichloroethene increases expression ISO RGD:1309345 6480464 Trichloroethylene results in increased expression of BCL6 mRNA CTD PMID:33387578 trichloroethene increases methylation ISO RGD:1309345 6480464 Trichloroethylene results in increased methylation of BCL6 gene CTD PMID:27618143 trichostatin A affects expression ISO RGD:1319642 6480464 trichostatin A affects the expression of BCL6 mRNA CTD PMID:28542535 tris(2-butoxyethyl) phosphate affects expression ISO RGD:1319642 6480464 tris(2-butoxyethyl) phosphate affects the expression of BCL6 mRNA CTD PMID:29024780 tunicamycin increases expression EXP 6480464 Tunicamycin results in increased expression of BCL6 mRNA CTD PMID:17127020 urethane increases expression ISO RGD:1319642 6480464 Urethane results in increased expression of BCL6 mRNA CTD PMID:28818685 valproic acid affects expression EXP 6480464 Valproic Acid affects the expression of BCL6 mRNA CTD PMID:17292431 vanadyl sulfate decreases expression ISO RGD:1319642 6480464 vanadyl sulfate results in decreased expression of BCL6 mRNA CTD PMID:16330358 vinclozolin decreases expression ISO RGD:1309345 6480464 vinclozolin results in decreased expression of BCL6 mRNA CTD PMID:23034163 vitamin E decreases expression ISO RGD:1319642 6480464 Vitamin E results in decreased expression of BCL6 mRNA CTD PMID:19244175
